Your browser doesn't support javascript.
loading
Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy.
Jeppesen, Catherine A; Snape, Matthew D; Robinson, Hannah; Gossger, Nicoletta; John, Tessa M; Voysey, Merryn; Ladhani, Shamez; Okike, Ifeanyichukwu O; Oeser, Clarissa; Kent, Alison; Oliver, Jennifer; Taylor, Pippa; Morales-Aza, Begonia; Clarke, Stuart C; Casey, Michelle; Martins, Filipa; Kitchin, Nicholas R E; Anderson, Annaliesa S; Jones, Hal; Jansen, Kathrin U; Eiden, Joseph; Pedneault, Louise; Heath, Paul T; Finn, Adam; Faust, Saul N; Pollard, Andrew J.
Afiliación
  • Jeppesen CA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK. Electronic address: Catherine.jeppesen@dchft.nhs.uk.
  • Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK.
  • Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK.
  • Gossger N; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK.
  • John TM; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK.
  • Voysey M; Primary Care Clinical Trials Unit, University of Oxford, Oxford, UK.
  • Ladhani S; Health Protection Services, Immunisation, Hepatitis and Blood Safety Department, Public Health England, 61 Colindale Avenue, London, UK.
  • Okike IO; Vaccine Institute & Paediatric Infectious Diseases Research Group, Division of Clinical Sciences, St George's, University of London, UK.
  • Oeser C; Vaccine Institute & Paediatric Infectious Diseases Research Group, Division of Clinical Sciences, St George's, University of London, UK.
  • Kent A; Vaccine Institute & Paediatric Infectious Diseases Research Group, Division of Clinical Sciences, St George's, University of London, UK.
  • Oliver J; Bristol Children's Vaccine Centre, University of Bristol, School of Cellular and Molecular Medicine and University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Taylor P; Bristol Children's Vaccine Centre, University of Bristol, School of Cellular and Molecular Medicine and University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Morales-Aza B; Bristol Children's Vaccine Centre, University of Bristol, School of Cellular and Molecular Medicine and University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Clarke SC; Academic Unit of Clinical and Experimental Sciences, Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK; Public Health England, Southampton, UK.
  • Casey M; Southampton NIHR Wellcome Trust Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Martins F; Southampton NIHR Wellcome Trust Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Kitchin NR; Vaccine Research, Pfizer Ltd., Maidenhead, UK.
  • Anderson AS; Vaccine Research, Pfizer Inc., Pearl River, NY, USA.
  • Jones H; Vaccine Research, Pfizer Inc., Pearl River, NY, USA.
  • Jansen KU; Vaccine Research, Pfizer Inc., Pearl River, NY, USA.
  • Eiden J; Vaccine Research, Pfizer Inc., Pearl River, NY, USA.
  • Pedneault L; Vaccine Research, Pfizer Inc., Pearl River, NY, USA.
  • Heath PT; Vaccine Institute & Paediatric Infectious Diseases Research Group, Division of Clinical Sciences, St George's, University of London, UK.
  • Finn A; Bristol Children's Vaccine Centre, University of Bristol, School of Cellular and Molecular Medicine and University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Faust SN; Academic Unit of Clinical and Experimental Sciences, Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK; Southampton NIHR Wellcome Trust Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK.
J Infect ; 71(1): 43-52, 2015 Jul.
Article en En | MEDLINE | ID: mdl-25709085
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Portador Sano / Infecciones Meningocócicas Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Humans / Male País/Región como asunto: Europa Idioma: En Revista: J Infect Año: 2015 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Portador Sano / Infecciones Meningocócicas Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Humans / Male País/Región como asunto: Europa Idioma: En Revista: J Infect Año: 2015 Tipo del documento: Article